Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) COO Amit Gupta sold 7,507 shares of the company’s stock in a transaction dated Tuesday, July 2nd. The shares were sold at an average price of $7.95, for a total transaction of $59,680.65. Following the transaction, the chief operating officer now owns 129,518 shares in the company, valued at $1,029,668.10. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Amit Gupta also recently made the following trade(s):
- On Wednesday, April 24th, Amit Gupta sold 23,416 shares of Cardlytics stock. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56.
Cardlytics Trading Up 6.1 %
NASDAQ CDLX opened at $8.31 on Thursday. Cardlytics, Inc. has a one year low of $5.69 and a one year high of $20.52. The company has a debt-to-equity ratio of 1.30, a current ratio of 2.13 and a quick ratio of 2.13. The firm has a market cap of $405.36 million, a P/E ratio of -1.88 and a beta of 1.65. The stock’s 50-day moving average is $9.74 and its 200-day moving average is $9.55.
Institutional Investors Weigh In On Cardlytics
Several institutional investors and hedge funds have recently added to or reduced their stakes in CDLX. Tower Research Capital LLC TRC increased its position in shares of Cardlytics by 349.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock valued at $88,000 after acquiring an additional 7,465 shares during the last quarter. SG Americas Securities LLC raised its holdings in Cardlytics by 34.3% in the 4th quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock valued at $198,000 after acquiring an additional 5,484 shares in the last quarter. Clear Street Markets LLC bought a new stake in shares of Cardlytics during the 4th quarter valued at $199,000. Banco Santander S.A. acquired a new stake in shares of Cardlytics during the 1st quarter worth $199,000. Finally, Check Capital Management Inc. CA increased its position in shares of Cardlytics by 14.0% in the fourth quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock worth $214,000 after purchasing an additional 2,850 shares during the period. 68.10% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have commented on the stock. Northland Capmk raised shares of Cardlytics to a “strong-buy” rating in a report on Tuesday, June 18th. Lake Street Capital upped their price objective on Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a report on Friday, March 15th. Bank of America restated a “neutral” rating and set a $11.00 target price on shares of Cardlytics in a report on Thursday, June 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $12.00 price target on shares of Cardlytics in a research note on Tuesday, June 11th. Finally, Northland Securities started coverage on shares of Cardlytics in a research note on Tuesday, June 18th. They set an “outperform” rating and a $14.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.67.
View Our Latest Stock Analysis on CDLX
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- What is the Australian Securities Exchange (ASX)
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How to invest in blue chip stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.